UNIPHARMA ApS: Financial statements 2023
CVR: 78881917
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
UNIPHARMA ApS (CVR 78881917) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK -88 the year before. Equity in the 2023 report amounted to DKK -124,033.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 0
- Equity
- DKK -124,033
- Total Assets
- DKK 0
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 0 | 0 | -124 t. | 0 |
| 2022 | 0 | 0 | -88 | 56 t. | - |
| 2021 | - | - | -5 t. | 57 t. | - |
| 2020 | -5 t. | -5 t. | -5 t. | 62 t. | - |
| 2019 | -5 t. | -5 t. | -5 t. | 67 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
UNIPHARMA ApS has published its annual report for 2022. Revenue came to DKK 0, and the net result was DKK -88.
As of May 1, 2023, Ole Reumert is registered as director of UNIPHARMA ApS.
About UNIPHARMA ApS
UNIPHARMA ApS is a Danish company of the type Anpartsselskab based in København K, founded in 1985. The company is under bankruptcy. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company is owned by Ebba Dorrit Reumert. According to the 2023 annual report, the company had an average of 0 employees. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2024 report amounted to DKK -124,033.